HemePath specializes in diagnostic evaluations and consultations necessary for the effective treatment of patients relating to disorders of blood, bone marrow and lymphoid tissue. Devoted solely to oncologists and hematologists, HemePath is directed by Timothy J. Dickason, M.D., board certified pathologist with subspecialty training in hematopathology and over two decades of experience diagnosing hematopoietic cells. Dr. Dickason is accompanied by Christopher Rubadue, M.D., both board certified hematopathologists. With this dynamic team, state-of-the-art laboratory technology and leading edge molecular testing capabilities, HemePath has become the local leader in diagnosing and managing hematologic malignancies.
- Bone marrow and Lymph node examination and interpretation
- Multi-parameter flow cytometry, cytogenics/FISH/ISH, Quantitative PCR
- Blood disease evaluation
- 24/48 hour turnaround time
FLOW Cytometry may be used as supportive evidence to a diagnosis determined through conventional means of morphology in conjunction to histochemical staining.
The high sensitivity of FLOW Cytometry makes it useful in confirming cell lineage to evaluate response to therapy and to aid in the staging of hematological malignancies. Specimens can include blood, bone marrow, tissue, and fluids.
